- The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.
- This year's edition set a new record: 259 projects submitted from 45 countries.
- The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened.
Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/
The Award Ceremony of the 12th edition of the IBSA Foundation Fellowship
The € 32,000 fellowships were awarded to research projects in five scientific areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy aging/regenerative medicine. In particular, this latter category has attracted growing interest over time, recording the highest number of applications this year: 89 projects out of a total of 259.
The winners of the 2024 edition are:
- Masami Ando Kuri, Wellcome Sanger Institute, Cellular genetics, Haniffa Lab, Cambridge, UK Scientific area: dermatology
- Enchen Zhou, University of California San Diego, Christopher Glass Laboratory, US Scientific area: endocrinology
- Ilaria Chiaradia, Charles Darwin Department of Biology and Biotechnology, Sapienza University of Rome, Italy Scientific area: fertility/urology
- Prach Techameena,Karolinska Institutet, Neurobiology of Pain Therapeutics, Saida Hadjab Group, Stockholm, Sweden Scientific area: pain medicine orthopaedics rheumatology
- Sergio Prez Diaz,Karolinska Institutet, Division of Clinical Physiology, Laboratory of Medicine Department, Stockholm, Sweden Scientific area: healthy aging regenerative medicine
- Vanessa Lpez Polo,University of California San Francisco, Cardiovascular Research Institute, US Scientific area: healthy aging/regenerative medicine
"Supporting the talent of young researchers represents for IBSA Foundation a strategic investment, driving scientific progress and fostering a society that is more aware and better equipped to face future challenges. In a context where access to a scientific career is increasingly complex, our Fellowships serve as a tangible tool to support young researchers at a difficult time, promoting merit and innovation", statedSilvia Misiti, Director of IBSA Foundation for scientific research
Since its launch in 2012, the IBSA Foundation Fellowships have attracted increasing interest, with 1,645 projects from 60 countries. Over twelve editions, 58 projects have been funded, totalling 1.6 million
A particularly noteworthy statistic is the high number of submissions from female researchers: 1,041 out of 1,645 applications, which testifies to their increasingly central role in international scientific research.
At the Milan (Italy) event, IBSA Foundation announced the opening of the 2025 call. Like in 2024, the new edition will award six 32,000 grants and will welcome projects in five areas: dermatology, endocrinology, fertility/urology, pain medicine/orthopaedics/rheumatology and healthy ageing/regenerative medicine. The sixth scholarship will be assigned to the category that receives the highest number of applications.
From this year, the IBSA Foundation Research Equity Prize will also be introduced: worth 5,000, the prize will be awarded to the best scientific project developed in a laboratory, research institute or university based in a developing country.
Researchers wishing to apply can submit their proposals by January 31, 2026, through the platform
About IBSA |
IBSA (Institut Biochimique SA) is a Swiss pharmaceutical multinational with 20 subsidiaries across Europe, China, and the United States. Its products are available in over 90 countries, and its R&D activities focus on 10 therapeutic areas. In 2025, IBSA will celebrate the 40th anniversary of its acquisition by current President and CEO, Arturo Licenziati, who has transformed the company into a multinational corporation employing over 2,300 personnel worldwide. IBSA's growth and development can be attributed to its ability to innovate by refining well-known molecules, as well as to its commitment to looking to the future responsibly and transparently, thanks to the dedication and dynamism of its people. |
About IBSA Foundation for scientific research |
Established in 2012 in Lugano by the pharmaceutical company IBSA (Institut Biochimique SA), IBSA Foundation for scientific research is the main promoter of IBSA Group's social responsibility activities.
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250522244202/en/
Contacts:
For further information:
furrerhugi Chérine Gurtner, Senior Consultant
cherine.gurtner@furrerhugi.ch
